Brief: Allarity Therapeutics Files Prospectus Supplement To Increase Offering Price Of Common Stock That May Be Offered From $2.4 mln To $3.2 mln
12/04/2024 19:21
April 12 (Reuters) - Allarity Therapeutics Inc ALLR.O :
* ALLARITY THERAPEUTICS INC: FILES PROSPECTUS SUPPLEMENT TO
INCREASE OFFERING PRICE OF COMMON STOCK THAT MAY BE OFFERED FROM
$2.4 MILLION TO $3.2 MILLION
Further company coverage: ALLR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allarity Therapeutics
See all newsBrief: Allarity Therapeutics Announces Strategic Capital Allocation For Filing Of Spac Registration Statement
Allarity Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Allarity Therapeutics Q2 loss narrows as expenses fall
Allarity Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Allarity Therapeutics Announces The Grant Of Essential U.S. Patent For Its Stenoparib Drp® Companion Diagnostic